Label-free Array Systems Market

Executive Summary

Label-free Array Systems Market was valued at US $1.38 billion in 2021 and is projected to grow at 6.52% CAGR over the forecast period to reach US $2.02 billion by 2027. Label-free Array Systems Market represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.64 billion opportunity in 2027 over 2021.

Label-free Array Systems from Consainsights analyses the Label-free Array Systems Market in the Life Sciences industry over the forecast period to 2027.

Label-free Array Systems research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Label-free Array Systems segmentation includes Technology, Application, End User and Geography.

Based on the Technology, the Label-free Array Systems analysis covers Surface Plasmon Resonance, Bio Layer Interferometry, Cellular Dielectric Spectroscopy, Other Technologies.

In Technology segment, Surface Plasmon Resonance segment has highest cagr growth of 5.78%.

Based on the Application, the Label-free Array Systems analysis covers Drug Discovery, Protein Interface Analysis, Antibody Characterization and Development, Protein Complex and Cascade Analysis, Other Applications.

In Application segment, Drug Discovery segment has highest cagr growth of 5.78%.

Based on the End User, the Label-free Array Systems analysis covers Contract Research Organizations, Agricultural Research Institutes, R&D Laboratories, Other End Users.

In End User segment, Contract Research Organizations segment has highest cagr growth of 5.78%.

Based on the region, the Label-free Array Systems analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Corning Incorporated, GE Healthcare, Bruker Corporation, Bio-rad Laboratories, Eppendorf AG, Fluiditic Analytics, ThermoFisher Scientific, Shimadzu Corporation, Danaher Corporation (Molecular Devices LLC - FORTEBIO), PerkinElmer and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Technology

Introduction

In 2021, Surface Plasmon Resonance segment has the highest revenue of US $0.63 billion and is expected to grow at CAGR of 5.78% by 2027 Surface Plasmon Resonance segment has highest cagr growth of 5.78%.

Surface Plasmon Resonance

Surface Plasmon Resonance segment was valued at US $0.55 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.92 billion by 2027. Surface Plasmon Resonance segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Bio Layer Interferometry

Bio Layer Interferometry segment was valued at US $0.30 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.49 billion by 2027. Bio Layer Interferometry segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.15 billion opportunity in 2027 over 2021.

Cellular Dielectric Spectroscopy

Cellular Dielectric Spectroscopy segment was valued at US $0.30 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.49 billion by 2027. Cellular Dielectric Spectroscopy segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Other Technologies

Other Technologies segment was valued at US $0.07 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.12 billion by 2027. Other Technologies segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.04 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Drug Discovery segment has the highest revenue of US $0.54 billion and is expected to grow at CAGR of 5.78% by 2027 Drug Discovery segment has highest cagr growth of 5.78%.

Drug Discovery

Drug Discovery segment was valued at US $0.47 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.79 billion by 2027. Drug Discovery segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

Protein Interface Analysis

Protein Interface Analysis segment was valued at US $0.32 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.53 billion by 2027. Protein Interface Analysis segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Antibody Characterization and Development

Antibody Characterization and Development segment was valued at US $0.20 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.33 billion by 2027. Antibody Characterization and Development segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.

Protein Complex and Cascade Analysis

Protein Complex and Cascade Analysis segment was valued at US $0.15 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.25 billion by 2027. Protein Complex and Cascade Analysis segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.08 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.13 billion by 2027. Other Applications segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.04 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Contract Research Organizations segment has the highest revenue of US $0.71 billion and is expected to grow at CAGR of 5.78% by 2027 Contract Research Organizations segment has highest cagr growth of 5.78%.

Contract Research Organizations

Contract Research Organizations segment was valued at US $0.63 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $1.04 billion by 2027. Contract Research Organizations segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.33 billion opportunity in 2027 over 2021.

Agricultural Research Institutes

Agricultural Research Institutes segment was valued at US $0.25 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.41 billion by 2027. Agricultural Research Institutes segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.

R&D Laboratories

R&D Laboratories segment was valued at US $0.21 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.35 billion by 2027. R&D Laboratories segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.11 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.13 billion in 2019 and is projected to grow at 5.78% CAGR over the forecast period to reach US $0.22 billion by 2027. Other End Users segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.